Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Intangibles (2016 - 2025)

Dexcom (DXCM) has disclosed Intangibles for 10 consecutive years, with $79.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Intangibles fell 25.61% to $79.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $79.0 million, a 25.61% decrease, with the full-year FY2024 number at $103.4 million, down 23.12% from a year prior.
  • Intangibles was $79.0 million for Q3 2025 at Dexcom, down from $87.2 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $163.6 million in Q1 2023 to a low of $22.6 million in Q3 2021.
  • A 5-year average of $93.9 million and a median of $103.4 million in 2024 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: surged 492.21% in 2023, then fell 26.51% in 2024.
  • Dexcom's Intangibles stood at $31.5 million in 2021, then skyrocketed by 383.81% to $152.4 million in 2022, then dropped by 11.75% to $134.5 million in 2023, then fell by 23.12% to $103.4 million in 2024, then fell by 23.6% to $79.0 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Intangibles are $79.0 million (Q3 2025), $87.2 million (Q2 2025), and $95.2 million (Q1 2025).